Your browser doesn't support javascript.
loading
One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary series.
Cramer, Jakob P; Jelinek, Tomas; Paulke-Korinek, Maria; Reisinger, Emil C; Dieckmann, Sebastian; Alberer, Martin; Bühler, Silja; Bosse, Dietrich; Meyer, Seetha; Fragapane, Elena; Costantini, Marco; Pellegrini, Michele; Lattanzi, Maria; Dovali, Claudia.
Afiliação
  • Cramer JP; Bernhard Nocht Institute for Tropical Medicine, Section Clinical Research and Epidemiology/University Medical Center Hamburg-Eppendorf, Bernhard Nocht Centre for Clinical Trials (BNCCT), Hamburg, Germany.
  • Jelinek T; Berlin Center for Travel and Tropical Medicine, Berlin, Germany.
  • Paulke-Korinek M; Institute of Specific Prophylaxis and Tropical Medicine, Medical University Vienna, Austria, Federal Ministry of Health, Vienna, Austria.
  • Reisinger EC; Department of Tropical Medicine and Infectious Diseases, University of Rostock Medical School, Rostock, Germany.
  • Dieckmann S; Institute of Tropical Medicine and International Health, Charité-Universitaetsmedizin Berlin, Germany.
  • Alberer M; Department of Infectious Diseases and Tropical Medicine, University of Munich, Munich, Germany.
  • Bühler S; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Bosse D; Novartis Vaccines and Diagnostics, GmbH, Marburg, Germany (a GSK company) and.
  • Meyer S; Novartis Vaccines and Diagnostics, GmbH, Marburg, Germany (a GSK company) and.
  • Fragapane E; Novartis Vaccines and Diagnostics, Srl (a GSK company), Siena, Italy.
  • Costantini M; Novartis Vaccines and Diagnostics, Srl (a GSK company), Siena, Italy.
  • Pellegrini M; Novartis Vaccines and Diagnostics, Srl (a GSK company), Siena, Italy michele.x.pellegrini@gsk.com.
  • Lattanzi M; Novartis Vaccines and Diagnostics, Srl (a GSK company), Siena, Italy.
  • Dovali C; Novartis Vaccines and Diagnostics, Srl (a GSK company), Siena, Italy.
J Travel Med ; 23(3)2016 Mar.
Article em En | MEDLINE | ID: mdl-26994987
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Raiva / Viagem / Vacina Antirrábica / Encefalite Japonesa / Vacinas contra Encefalite Japonesa / Profilaxia Pré-Exposição Tipo de estudo: Clinical_trials Limite: Adult / Animals / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Travel Med Assunto da revista: DOENCAS TRANSMISSIVEIS / SAUDE PUBLICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Raiva / Viagem / Vacina Antirrábica / Encefalite Japonesa / Vacinas contra Encefalite Japonesa / Profilaxia Pré-Exposição Tipo de estudo: Clinical_trials Limite: Adult / Animals / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: J Travel Med Assunto da revista: DOENCAS TRANSMISSIVEIS / SAUDE PUBLICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha